Average daily glucocorticoid dose, number of prescription days, and cumulative dose in the initial 90 days of glucocorticoid therapy are associated with subsequent hip and clinical vertebral fracture risk: a retrospective cohort study using a nationwide health insurance claims database in JapanMasayuki Iki, Sumito Ogawa, Hironori Imano et al.|Osteoporosis International|2024Cited by 15
Rapid reduction in fracture risk after the discontinuation of long-term oral glucocorticoid therapy: a retrospective cohort study using a nationwide health insurance claims database in JapanMasayuki Iki, Sumito Ogawa, Kenji Fujimori et al.|Osteoporosis International|2024Cited by 8
Author Response to: Comment from Cheng Gu and Yu Cui on: Rapid reduction in fracture risk after the discontinuation of long-term oral glucocorticoid therapy: a retrospective cohort study using a nationwide health insurance claims database in JapanMasayuki Iki, Sumito Ogawa, Hironori Imano et al.|Osteoporosis International|2024Cited by 1